OUP (Osage University Partners) — Full Portfolio

Ambiq develops ultra-low-power semiconductor solutions and edge AI platforms for IoT and healthcare applications.

AI & Machine LearningIoTSemiconductorsAustin, US

SHScott Hanson(Founder)inDSDennis Sylvester(Founder)inFEFumihide Esaka(CEO)inSGScott Goodwin(Executive Officer)inJoseph A. Tautges(Director)PRPaul Rolls(Executive Officer)

Co-investorsCICisco InvestmentsCOConductive VenturesKLKleiner PerkinsMAMatter Venture PartnersMEMercury FundMIMichigan Capital Network+5 more

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

DRDavid R. Liu(Founder)inJKJ. Keith Joung(Founder)inFZFeng Zhang(Founder)DRDavid R. Liu, Ph.D.(Founder and Inventor)JKJ. Keith Joung, M.D., Ph.D.(Founder and Inventor)FZFeng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARARCH Venture PartnersDRDreamers VCEIEight Roads VenturesF-F-Prime CapitalFOForesite CapitalGVGV (Google Ventures)+2 more

Context Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors.

BiotechHealthtechPhiladelphia, US

MLMartin Lehr(Founder)inJMJennifer Minai-Azary(Executive Officer)inALAlex Levit(Executive Officer)Linda Beth West(Director)Richard Jay Berman(Director)PKPhilip Kantoff(Director)in

Co-investorsNENextech InvestTOTorrey Pines Investment

Evolv Technologies provides artificial intelligence-powered screening systems for weapons detection at facilities including schools, hospitals, stadiums, and workplaces, delivered through a subscription model that combines proprietary sensor hardware, cloud-based software, and analytics dashboards with ongoing support services.

Waltham, US

ACAnil Chitkara(Executive Officer)Michael Ellenbogen(Executive Officer, Director)Kevin O'Brien(Executive Officer)John Kedzierski(Chief Executive Officer, President, and Director)inGeorge C. Kutsor(Chief Financial Officer)Robert Marshall(Chief Revenue Officer)in

Co-investorsDCDCVC (Data Collective)LULux Capital

Gevo produces low-carbon drop-in fuels and chemicals — including motor fuels, sustainable aviation fuel (SAF), and renewable materials — using CO2 as a renewable carbon source.

CleantechClimate TechEnergyEnglewood, US

Christopher Ryan(Executive Officer)MWMike Willis(Executive Officer)GRGreg Roda(Executive Officer)PGPatrick Gruber(Executive Officer, Director)inBrett Lund(Executive Officer)Paul D. Bloom(Chief Executive Officer and Director)in

Co-investorsGIGiant Leap

Guardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease.

BiotechDigital HealthHealthtechMedical DevicesRedwood City, US

ATAmirAli Talasaz(Founder)inHEHelmy Eltoukhy(Founder)inMWMichael Wiley(Executive Officer)inMichael Bell(Chief Financial Officer)Darya Chudova(Chief Technology Officer)inCECraig Eagle(Chief Medical Officer)in

Co-investors8V8VCAUAUTHENTIC VENTURESCLCLI VenturesCOCota CapitalFEFelicis VenturesKHKhosla Ventures+11 more

Kura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.

BiotechDigital HealthMedical DevicesLa Jolla, US

PINGDA REN(Executive Officer)inYLYI LIU(Executive Officer)inTWTroy Wilson(Founder)inTWTroy Wilson, Ph.D., J.D.(Co-founder; President, Chief Executive Officer and Chairman of the Board)Kevan M. Shokat, Ph.D.(Founding team member)HEIDI HENSON(Executive Officer)in

Co-investorsARARCH Venture PartnersAVAvoro Capital AdvisorsECEcoR1 CapitalFOForesite CapitalNENextech Invest

A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.

BiotechMedia & EntertainmentAustin, US

Matthew Winkler(Director)Sinil Kim(Executive Officer)inPLPaul Lammers(Executive Officer, Director)inJon Irvin(Executive Officer)Casi DeYoung(Executive Officer)

BoardMichael Powell(Director)

Co-investorsNENew Enterprise Associates (NEA)PFPfizer Venture InvestmentsCOCorrelation VenturesOROrbiMedPFPfizer VenturesSOSofinnova Ventures

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

MKMATTHEW KANE(Executive Officer, Director)JSJeff Smith(Co-founder)inDJDerek Jantz(Co-founder)inTODD MELBY(Executive Officer)inMAMichael Amoroso(President, Chief Executive Officer)in

BoardRAROBERT ADELMAN(Director)

Co-investorsAGage1AGAgent CapitalALAliment CapitalBRBrace PharmaF-F-Prime CapitalOCOCV Partners+6 more

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R.

BiotechDeep TechHealthtechMedical Devices

AAAndrew Anzalone(Founder)inDLDavid Liu(Co-founder)inARAllan Reine(Chief Executive Officer)inMAMohammed Asmal(Chief Medical Officer)inALAnn Lee(Chief Technical Officer)inSMSvetlana Makhni(Chief Financial Officer)in

Co-investorsARARCH Venture PartnersGVGV (Google Ventures)NENewpath PartnersF-F-Prime CapitalSASamsara BioCapitalARArrive+1 more

Q32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis.

BiotechHealthtech

SVShelia Violette(Founder & Chief Scientific Officer)inMichael Holers(Co-founder)JMJodie Morrison(Chief Executive Officer)inLKLee Kalowski(President & Chief Financial Officer)MMMaria Marzilli(Chief Business Officer)inDADavid Appugliese(Senior Vice President, Head of People)in

Co-investorsATAtlas VentureOROrbiMedAGAgent CapitalCUCU Healthcare Innovation FundSASanofi Ventures5A5AM Ventures+2 more

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.

BiotechDigital HealthFemTechHealthtechSalt Lake City, US

Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)inGregory C. Critchfield(Executive Officer, Director)inAAAndrew A. Sauter(Executive Officer)inZhenya Lindgardt(President and Chief Executive Officer)in

BoardMansoor Mirza(Director)

Co-investorsAMaMoonEXExcelestar VenturesINIntermountain HealthUPUpStart VenturesVIVivo CapitalCACatalyst Health Ventures+1 more

Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, led by SP001, a third-generation anti-CD40L antibody targeting IgG4-related disease.

BiotechCambridge, US

AMAnkit Mahadevia(Executive Officer, Director)inSGStephen Garbacz(Executive Officer)inEsther Rajavelu(Director, President, Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer)in

BoardJFJean-Francois Formela(Director)inReza Halse(Director)Casper Breum(Director)

Co-investorsGVGV (Google Ventures)HEHEALTHCARE ROYALTY PARTNERSMRMRL Ventures FundRARA CapitalALAlphabetATAtlas Venture+1 more

Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men.

BiotechHealthtechWest Hartford, US

RWReid Waldman(Chief Executive Officer and Board Member)inTDTim Durso(Chief Technical Officer)inDCDominic Carrano(Chief Financial Officer and Treasurer)inMNMark Neumann(Chief Commercial and Strategy Officer)John W. Childs(Director)Jane Grant-Kels(Director)

Co-investorsLOLongitude CapitalCOConnecticut InnovationsLILifeSci Venture PartnersSRSR One Capital ManagementABabrdn plcINInvus

Vor Biopharma is a biopharmaceutical company.

BiotechCambridge, US

Nathan Jorgensen(Executive Officer)Amy Mendel(Executive Officer)RARobert Ang(Executive Officer, Director)JKJean-Paul Kress(President, Chief Executive Officer and Chairman of the Board)in

BoardKPKush Parmar(Director)inJoshua Resnick(Director)

Co-investors5A5AM VenturesRARA CapitalPUPureTech Health

Eridu develops networking infrastructure optimized for artificial intelligence workloads.

AI & Machine LearningCloud ComputingDeep TechHardwareSaratoga, US

DPDrew Perkins(Founder)inBKBrian Kinard(Executive Officer)in

BoardJagdeep Singh(Director)Dipender Saluja(Director)WHWen Hsieh(Director)inChristian Gallagher(Director)

Co-investorsBOBosch VenturesCACatapult VenturesMAMatter Venture PartnersSOSocratic PartnersTDTDK VenturesZEZelda Ventures+13 more

Aerie Pharmaceuticals develops ophthalmic pharmaceutical products including Rocklatan and Rhopressa for glaucoma and ocular hypertension, and AR-15512 for dry eye disease.

BiotechHealthtechMedical DevicesBedminster, US

CASEY KOPCZYNSKI(Executive Officer)inVICENTE ANIDO(Executive Officer, Director)BLBRIAN LEVY(Executive Officer)RICHARD RUBINO(Executive Officer)THOMAS MITRO(Executive Officer)DEDavid Endicott(CEO of Alcon)in

Co-investorsALAlta PartnersAVAvoro Capital AdvisorsFOForesite CapitalSOSofinnova Ventures

Agita Labs develops hardware security and computer architecture technology focused on secure computation and side-channel resistance techniques.

CybersecurityDeep TechHardwareAnn Arbor, US

Valeria Bertacco(Co-founder)Todd Austin(Co-founder)Amy Wirth(Chief Financial Officer)Lip-Bu Tan(Director)

Algorithmia offers an enterprise AI platform for developing, deploying, and governing machine learning models and AI applications, with tooling tailored to roles across data science, engineering, DevOps, and IT teams.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSeattle, US

Kenneth F. Daniel(Executive Officer, Director)DMDiego M. Oppenheimer(Executive Officer, Director)inDiego Oppenheimer(Founder)Kenny Daniel(Founder)

BoardTPTimothy Porter(Director)inAPAnna Patterson(Director)in

Co-investorsGRGradient VenturesINIn-Q-TelMAMadrona Venture GroupDEDeep Fork CapitalNONorwest Venture PartnersRARakuten Capital+1 more

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

BFBarbara Fox(Executive Officer, Director)inNicholas J Galli(Executive Officer, Director)SCStanley Choy(Executive Officer)inRBRanjit Bindra(Director)in

BoardCCColleen Cuffaro(Director)inMCMatthew Cohen(Director)in

Co-investorsCACanaan PartnersCOConnecticut InnovationsHIHighCape Capital

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.

BiotechFemTechHealthtechMedical DevicesRedwood City, US

KYKarl Y. Hostetler(Executive Officer, Director)inGMGail Maderis(Director)inKBKristine Ball(President & CEO)inECElaine Chien(Executive Officer)inSarah Walter(Executive Officer)inRGRaju Gadiraju(Executive Officer)in

Co-investorsADAdjuvant CapitalAVAvestria VenturesBRBrace PharmaCACanaan PartnersGAGaingelsGVGV (Google Ventures)+6 more

BiotechEvanston, US

Joseph R. Moskal(Chief Scientific Officer)Torsten M. Madsen(Chief Marketing Officer)Ashish Khanna(Secretary & Chief Business Officer)Norbert G. Riedel(Chief Executive Officer)

BoardLiam Ratcliffe(Director)Terry P. Gould(Director)

Co-investorsBABain Capital Life SciencesFRFrazier Life SciencesLALatterell Venture PartnersLOLongitude CapitalAGAgent CapitalBABain Capital+3 more

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

MGMichael Gilman(Executive Officer, Director)inMDMark DeLong(CEO)inDNDavid Neafus(Executive Officer)inRussell C. Petter(Executive Officer)

BoardCCColleen Cuffaro(Director)inAEAlan E. Walts(Director)in

Co-investorsCACanaan PartnersPFPfizer VenturesADAdvent Life SciencesHBHBM Healthcare InvestmentsHBHBM PartnersNENextech Invest+2 more

Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.

BiotechHealthtechMedical DevicesSouth San Francisco, US

KDKen Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)Alexander Marson(Founder)Kole Roybal(Founder)

Co-investorsARARCH Venture PartnersHIHitachi VenturesKLKleiner PerkinsLULuma GroupSOSoftBank Vision FundWEWestlake Village BioPartners+4 more

AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.

Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US

William Zell(Executive Officer, Director)WRWilliam Ruff(Executive Officer)inRobert Lee(Director)inTad Dritz(VP of Development)inJHJeff Haskett(COO)inBGBrian Graham(Executive Officer, Director)in

Co-investorsCECerity Partners VenturesG2G2 Venture PartnersHAHarmonic Growth PartnersJOJobsOhio VenturesMOMonte Carlo CapitalTRTriangle Peak Partners+4 more

Biohaven is a biopharmaceutical company that discovers, develops, and commercializes treatments across immunology, obesity, neuroscience, and oncology, targeting rare and common diseases with limited treatment options.

BiotechHealthtech

VCVlad Coric(Chairman & Chief Executive Officer)in

Co-investorsAIAisling CapitalAPAPERTURE Venture PartnersCOConnecticut InnovationsHBHBM Healthcare InvestmentsOROrbiMed

Brimstone develops co-production processes to manufacture cement, steel, aluminum, and other critical minerals from a single feedstock in an integrated facility.

Advanced ManufacturingCircular EconomyCleantechConstruction TechNew MaterialsOakland, US

CFCody Finke(Founder)inHugo Leandri(Founder)in

Co-investorsACAccelr8BRBreakthrough Energy VenturesCOCollaborative FundCRCreative Destruction Lab (CDL)DCDCVC (Data Collective)FIFifth Wall+7 more

BiotechLafayette, US

PEPeter Emtage(Executive Officer)inGreg Giotta(Executive Officer)Brian Atwood(Executive Officer, Director, Promoter)

BoardFred Cohen(Executive Officer, Director, Promoter)BBBrook Byers(Director)inArie Belldegrun(Director)

Co-investorsKLKleiner PerkinsMIMission Bay CapitalMIMission Biocapital

Censys operates an Internet-wide scanning map that provides real-time data on Internet infrastructure, delivered through a platform for exploring exposure, dependencies, and attacker infrastructure.

CybersecurityData & InfrastructureSaaSAnn Arbor, US

J. Alex Halderman(Founder)ZDZakir Durumeric(Founder)inBrad Brooks(Former CEO)David Corcoran(Founder)LGLorne Groe(Former Interim CEO; later CFO/COO)SASarah Ashburn(Chief Revenue Officer)

Co-investorsASAscension VenturesDEDecibel PartnersGRGreylock PartnersGVGV (Google Ventures)HAHamilton LaneINIntel Capital+3 more

nChroma Bio is a genetic medicines company developing in vivo therapies that pair genetic cargoes with targeted delivery technologies.

BiotechLongevityBoston, US

Angelo Lombardo(Founder)David R. Liu(Founder)J. Keith Joung(Founder)Jonathan S. Weissman(Founder)Luigi Naldini(Founder)Luke Gilbert(Founder)

Co-investorsWEWellington ManagementATAtlas VentureCACasdin CapitalGVGV (Google Ventures)NENewpath Partners

Clarifai developed AI inference technology and compute orchestration software for running and optimizing machine learning models at scale.

AI & Machine LearningCloud ComputingData & InfrastructureNew York, US

MZMatthew Zeiler(Founder)in

BoardAWAlbert Wenger(Director)in

Co-investorsBRBright Pixel CapitalCOCorazon CapitalGVGV (Google Ventures)LULux CapitalMEMenlo VenturesNENew Enterprise Associates (NEA)+10 more

BiotechBurlingame, US

Mark Rolfe(Executive Officer)LSLaura Shawver(Executive Officer, Director)inTimothy Smith(Executive Officer)

BoardASAlfred Scheidegger(Director)inPTPeter Thompson(Director)inCGCarol Gallagher(Director)in

Co-investorsASAstellas Venture Management LLCNENew Enterprise Associates (NEA)NENextech Invest5A5AM VenturesCLClarus VenturesOROrbiMed+1 more

Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials.

BiotechDigital HealthHealthtechMorrisville, US

Mark Ubert(Executive Officer)Jesse Watson(Director)Brian Carney(Director)Jeff L. Williams(Executive Officer, Director)Melissa Daniels(Director)Christopher K. Porter(Executive Officer)

Co-investorsCRCreathor VenturesHAHatteras Venture Partners

Corelight provides network detection and response (NDR) software that uses agentic triage to automatically consolidate security alerts into entity-centric cases with evidence-backed investigation summaries.

AI & Machine LearningCybersecurityEnterprise Software

SHSeth Hall(Founder)inGregory Bell(Chief Strategy Officer & Co-Founder)inBrian Dye(CEO)inGreg Bell (CEO)(Founder)Robin Sommer(Founder)Vern Paxson(Founder)

Co-investorsACAccelCICisco InvestmentsDEDelta-v CapitalENEnergy Impact PartnersFLFlucas VenturesGAGaingels+7 more

Crozet, US

Randy Caldejon(Chairman, Chief Executive Officer and President)EBErik Breuhaus(Chief Financial Officer)Peter Shaw(Vice President)in

BoardMatthew Swartz(Director)

Co-investorsTFTFX CapitalTITiburon

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.

BiotechHealthtechCambridge, US

Kevin Mills(Executive Officer, Director)inRGRonald Goldstein(Executive Officer)inDCDonald Corcoran(Executive Officer, Director)inMRMarkus Renschler(Director)in

BoardTimothy Romberger(Director)Barry Mills(Director)

Co-investorsDRDroia VenturesLILightstone VenturesSHShah Family OfficeALAlly Bridge GroupDEDe Novo VenturesJAJanus Henderson Investors+3 more

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US

VVVictor Velculescu(Founder)inPBPeter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)inSTSusan Tousi(Chief Executive Officer)in

Co-investorsAVAV8 VenturesFOForesite CapitalILIllumina VenturesINInitiate Venture PartnersMEMenlo VenturesMEMerck Global Health Innovation Fund+7 more

Dracen Pharmaceuticals is a private drug developer working at the intersection of cancer metabolism and immuno-oncology, developing glutamine antagonists that inhibit tumor glutamine metabolism and remodel the tumor microenvironment.

BiotechHealthtechBaltimore, US

Robert Wild(Co-founder & Chief Scientific Officer)TMThomas M. Estok(Chief Executive Officer, President and Treasurer)Drew Pardoll, M.D., Ph.D.(Director)

BoardJLJonathan Leff(Director)Robert Jackson(Director)

Co-investorsBIBiotech Investments S.R.OI&i&i Biotech FundDEDeerfield Management CompanySOSofinnova Ventures

eFFECTOR Therapeutics was a clinical-stage biopharmaceutical company.

BiotechSolana Beach, US

Stephen F. Worland, Ph.D.(Executive Officer, Director)AMAlana McNulty(Executive Officer)in

BoardSimeon George(Director)JRJonathan Root(Director)inKen Haas(Director)Laurence Lasky(Director)

Co-investorsASAstellas Venture Management LLCMIMission Bay CapitalMIMission BiocapitalPFPfizer Venture InvestmentsUSUS Venture PartnersSOSofinnova Ventures

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

BiotechBrookline, US

Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)

BoardGMGeorge M. Church(Director)

Co-investorsALAlta PartnersARARCH Venture PartnersCACatalio Capital Management, LPHBHBM Healthcare InvestmentsHBHBM PartnersKHKhosla Ventures+12 more

Elementary builds data observability tools that monitor data quality and reliability for modern data teams.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareTel Aviv-Yafo, IL

MSMaayan Salom(Founder)inOAOr Avidov(Founder)in

Co-investorsCOCowboy VenturesICICON - Israel Collaboration NetworkMOModern TechnicalY Y CombinatorACAccuro TrusteesTETetration Labs+2 more

Elementary Robotics develops machine vision inspection systems for industrial quality control and defect detection.

Advanced ManufacturingAI & Machine LearningRobotics

ABArye Barnehama(Founder)

Co-investorsIDIdealabRIRiot VenturesTHThundermark CapitalFAFathom CapitalFIFika VenturesRERewired+4 more

EnaChip develops integrated magnetic structures — thin, small inductors fabricated with semiconductor-compatible electroplating — for point-of-load power delivery in AI infrastructure, advanced packaging, chiplets, and edge systems.

Deep TechHardwareSemiconductorsWilmington, US

Trifon M Liakopoulos(Executive Officer, Director, Promoter)MAMark Allen(Co-Founder & CTO)MPMark Popovich(CEO)inMichael Cassidy(Director)Michael Poisel(Director)

BoardMBMICHAEL BURYCHKA(Director)in

Co-investorsANAnzu PartnersBOBoston Seed Capital

Company developing molecules targeting a novel class of receptors for neuro-immuno-inflammatory diseases; acquired by Incyte in May 2024.

BiotechSan Diego, US

Alain Baron(Founder)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Founder)

BoardASAndrew Schwab(Director)in

Co-investors5A5AM VenturesAVAvego BioScience CapitalNENew Enterprise Associates (NEA)SASanofi VenturesTHThe Column GroupABAbingworth+2 more

Everactive develops ultra-low power, self-powered systems-on-chip (SoCs) for Ambient IoT devices that sense, process, and wirelessly transmit data using harvested environmental energy instead of batteries.

HardwareIoTSemiconductorsSan Jose, US

BCBenton Calhoun(CEO and Co-Founder)inDavid Wentzloff(CTO and Co-Founder)inBrendan R Richardson(Executive Officer, Director)

BoardGeorge Kastendike(Director)GPGreg Papadopoulos(Director)inJack Busch(Director)

Co-investorsASAsahi Kasei Corporate Venture CapitalBLBlue Bear Capital PartnersINIn-Q-TelNENew Enterprise Associates (NEA)ABABB Technology VenturesFLFluke Venture Partners+1 more

Zhiming Shen(Founder)in

Co-investorsCACambium CapitalCACandou VenturesCECelesta CapitalEAEastlink Capital PartnersGAGaingelsLALaunch NY+2 more

Seattle biotech that developed FDY-5301 for cardiac and skeletal muscle injury; ceased operations in February 2026.

BiotechSeattle, US

MRMark Roth(Executive Officer, Director, Promoter)Brian Blackman(Executive Officer)Simon Tulloch(Executive Officer)SHStephen Hill(Executive Officer, Director)

BoardPHPaulina Hill(Director)inSGSteven Gillis(Executive Officer, Director, Promoter)in

Co-investorsARARCH Venture PartnersPOPolaris Partners

Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas.

BiotechHealthtechMedical DevicesSan Diego, US

Marc Nasoff(Chief Scientific Officer)

BoardJBJay B. Lichter(Ph.D.)in

Co-investorsVIVivo CapitalLILilly Asia VenturesAVAvalon BioVentures

Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.

BiotechDeep TechBerkeley, US

DEDaniel Estandian(Founder)inEd Boyden(Founder)JYJosh Yang(Founder)inJoshua Yang(Founder)

BoardCACraig Asher(Director)inJYJimmy Yun(Director)in

Co-investorsARArtis VenturesBLBlack FlagCICivilization Ventures Management, LlcFOFoundersX VenturesGAGaingelsHAHarpoon Ventures+10 more

Hack The Box provides hands-on training and simulation platforms for cybersecurity blue teams, including labs, courses, and incident response exercises designed to develop skills in SOC operations, digital forensics, and threat hunting.

AI & Machine LearningCybersecurityDeveloper ToolsEdTechEnterprise Software

Co-investorsBRBrighteye VenturesMAMarathon Venture CapitalPAPaladin Capital Group

Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.

BiotechBedford, US

Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)

BoardSteven Gillis(Director)ATArthur Tzianabos(Executive Officer, Director)KPKush Parmar(Director)inRichard Gregory(Director)

Co-investors5A5AM VenturesARARCH Venture PartnersALAlexandriaDEDeerfield Management CompanyFIFidelity InvestmentsHBHBM Healthcare Investments+5 more

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

CVCarl Vause(Executive Officer, Director)inMSMira Sahney(Executive Officer, Director)inDMDavid Myung(Director)

BoardMichael Hawkins(Director)WHWende Hutton(Director)inWHWilliam Harrington(Director)in

Co-investorsCACanaan PartnersTRTreo Ventures, LlcJOJohnson & Johnson Innovation – JJDC

Immunotherapy oncology company engineering technologies to activate the immune system; acquired by Merck in February 2019 for $0.3B.

BiotechHealthtechMedical DevicesSeattle, US

DBDavid Baltimore(Director)Carlos V. Paya(Executive Officer, Director)Stephen R. Brady(Executive Officer)inJHJan Henrik ter Meulen(Executive Officer)Paul Rickey(Executive Officer)inWayne Gombotz(Executive Officer)in

Co-investorsAIAisling CapitalATAtlas VentureHMHM Venture PartnersSASanderling VenturesSASanofi VenturesSPSPRINGROCK VENTURES+4 more

Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions.

BiotechDigital HealthChapel Hill, US

Jenny Ting(Director and Co-founder)Matthew Cohen(Director)Lev Osherovich(Director)Mark Vellaca(Director)Anil Goyal(CEO and Director)

BoardBenjamin Scruggs(Director)

Co-investorsDEDelin VenturesHAHatteras Venture Partners

IgniteTech is an AI-first enterprise software company that acquires, revitalizes, and supports a portfolio of mission-critical software products for organizations worldwide.

AI & Machine LearningEnterprise SoftwareSaaS

Eric Vaughan(CEO)

Infinite Uptime builds PlantOS, a prescriptive AI platform for heavy manufacturing that reads mechanical and process-induced fault signatures to tell plant operators which equipment fault to fix, why, and by when.

Advanced ManufacturingAI & Machine LearningIoTMenlo Park, US

Raunak Bhinge(Founder & MD)inJean-David Margulici(Executive Officer, Director)Yung Chih Chen(Founder)Karthikeyan Natarajan(Chief Executive Officer)

Co-investorsAVAvataar Venture PartnersDODorm RoomGIGiTV, Inc.MAMayfield FundPEPear VCTDTDK Ventures+3 more

BiotechPhiladelphia, US

Philip R. Johnson, M.D.(Executive Officer, Director)inDora Mitchell(Executive Officer)LFLori Forrest(Executive Officer)Leon Moulder, Jr.(Director)BLBenjamin Lund(Director)in

BoardTomas Kiselak(Director)

Co-investorsAGAgent CapitalDCDC Investment PartnersLOLongwood FundPFPfizer Venture InvestmentsQUQuan CapitalBABain Capital Life Sciences+3 more

BiotechSan Diego, US

Kevin Forrest, Ph.D.(Executive Officer, Director)

BoardClare Ozawa, Ph.D.(Director)Beth Seidenberg, M.D.(Director)

Co-investorsWEWestlake Village BioPartnersKLKleiner PerkinsVEVersant Ventures

Vertically-integrated machine learning platform for healthcare powering transition to value-based care with predictive analytics.

Co-investorsMIMindset VenturePOPolaris Partners

Kymeta develops flat-panel satellite antennas and connectivity terminals, including its u5 and u8 product lines, that switch between LEO and GEO networks for mobile land and maritime use.

Defense TechHardwareSpace TechRedmond, US

MSMarc Stolzman(Executive Officer)inBill Marks(Executive Officer)Keith Cochran(Executive Officer)inMMManny Mora(CEO)inAnne(Chief Financial Officer)inRyan(Chief Scientist)in

Co-investorsLULux CapitalMAManta Ray VenturesTETectonic VenturesINIntellectual Ventures

American network security company offering malware sandboxing and AI-based network detection and response; acquired by VMware in 2020.

Redwood City, US

GVGiovanni Vigna(Executive Officer, Director)Engin Kirda(Executive Officer)CKChristopher Kruegel(Executive Officer)Jens Andreassen(Executive Officer, Director)

BoardJWJohn Walecka(Director)inAndreas Von Blottnitz(Director)

Co-investorsPRPresidio VenturesRERedpoint VenturesBABallistic VenturesHEHeadlineNTNTT FinanceTHThomvest Ventures

Global leader in silicon photonics, first to achieve direct 'fiber to the chip' integration on CMOS.

Carlsbad, US

EYEli Yablonovitch(Director)Greg Young(Executive Officer, Director)inTom Foody(Executive Officer)Axel Scherer(Founder)

BoardAndy Rappaport(Director)RCRohini Chakravarthy(Director)in

Co-investorsATATEL VenturesAUAugust CapitalCICisco InvestmentsTETEL Venture Capital, Inc.NENew Enterprise Associates (NEA)

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

BiotechDigital HealthHealthtechMedical DevicesLexington, US

John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)

BoardMSMarc Singer(Director)in

Co-investorsBRBraemar Energy VenturesMIMitsui Global InvestmentWIWindham Capital PartnersABAberdare VenturesNONorth Bridge Venture Partners & Growth Equity

Menlo Security provides a browser security platform that protects both human users and AI agents through a hybrid architecture combining local security controls with cloud-based threat protection.

AI & Machine LearningCybersecurityEnterprise SoftwareMountain View, US

ABAmir Ben-Efraim(Founder)inPoornima DeBolle(Founder)in

Co-investorsBABaruch Future VenturesENEngineering CapitalGEGeneral CatalystJUJuniperoVIVista Equity PartnersWIWillowTree Ventures+3 more

Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.

Deep TechHardwareSemiconductorsStoneham, US

FCFederico Capasso(Co-founder)inRDRob Devlin(Co-Founder and CEO)in

BoardXSXuhui Shao(Director)in

Co-investorsBABantam GroupBRBraemar Energy VenturesFOFoothill VenturesGLGlobal BrainINIntel CapitalM M Ventures+5 more

Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment.

HealthtechMedical Devices

JCJordan Curnes(Co-Founder)in

Co-investorsGRGreen Park & Golf VenturesLOLongitude CapitalUSUS Venture Partners

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.

BiotechHealthtechMedical DevicesAliso Viejo, US

David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)JJJon J. Snyder(Director, President, Secretary and CEO)in

BoardJEJoyce Erony(Director)inWHWilliam Harrington(Director)in

Co-investorsAMAmzak HealthAPAPERTURE Venture PartnersCWCWRU Technology VenturesISiSelect FundJOJobsOhio VenturesJUJumpstart Ventures+5 more

Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.

BiotechHealthtechMedical DevicesWatertown, US

MATTHEW FRANKEL(Executive Officer)inPCPETER COUROSSI(Executive Officer)RICHARD BATYCKY(President and Chief Executive Officer)JAMES ELLIS(Executive Officer)MLMICHAEL LIPP(Executive Officer)inCSCHRISTOPHER SILBER(Executive Officer)in

Co-investorsCACanaan PartnersF-F-Prime CapitalLULumira VenturesMIMission BiocapitalMOMonograph Capital Partners

Normunity develops biologic anti-cancer therapies that act at the interface of the immune system and tumors, targeting mechanisms tumors use to evade immune surveillance.

BiotechHealthtech

RHRachel Humphrey(Founding Chief Executive Officer)inLieping Chen(Scientific Founder)MKMitchell Keegan(Chief Development Officer)inWLWilliam LaRochelle(Chief Scientific Officer)inSMStacy M. Plum(Chief Technology Officer)

Co-investorsSASanofi VenturesTATaiho Ventures, LLCPFPfizer VenturesSASamsara BioCapitalCACanaan PartnersCOConnecticut Innovations+6 more

Opsys develops solid-state scanning LiDAR sensors with no moving parts, using VCSEL and SPAD chip technology for autonomous driving and industrial applications.

AI & Machine LearningDeep TechHardwareRoboticsIsrael, IL

Guy Gertel(Founder)Rafi Harel(Founder)

Co-investors8383NorthSASaban VenturesTRTransLink Capital

Overland AI develops ground autonomy solutions for military vehicles and land operations, enabling autonomous mobility without human operators.

AI & Machine LearningDefense TechRoboticsSeattle, US

BBByron Boots(Founder)inSBStephanie Bonk(Founder)inGOGreg Okopal(Founder)inJonathan Fink(Executive Officer)

BoardChristopher Morales(Director)

Co-investors8V8VCALAlumni VenturesASAscend Venture CapitalCUCubit CapitalOVOvermatchPIPioneer Square Labs+7 more

Picwell operates ALEX, a benefits decision-support platform that combines plan recommendations, enrollment, benefits administration, and year-round guidance for employees.

HR TechInsurTechSaaSPhiladelphia, US

Thomas Baker(Executive Officer, Director)Jonathan Thompson Kolstad(Executive Officer, Director)Robert James Town(Executive Officer, Director)Jay Silverstein(Executive Officer, Director)inAnirudh Vemprala(Executive Officer, Director)

BoardKevin Hill(Director)

Co-investorsBLBlue Venture FundsMAMassMutual VenturesSESeaX VenturesBLBlueCross BlueShield Venture Partners

HealthtechSan Francisco, US

Matthew F. Krummel, Ph.D.(Director)SPSteven P. James(Executive Officer, Director, Promoter)inLeon Chen, Ph.D.(Director)CGCarol Gallagher(Director)inJoshua Resnick, M.D.(Director)

BoardMichael Powell(Director)

Co-investorsMIMission Bay CapitalMIMission BiocapitalNENew Enterprise Associates (NEA)SOSofinnova VenturesOROrbiMedSOSofinnova Venture Partners

PMV Pharma is a precision oncology company developing therapies that selectively target mutant p53 to treat cancers whose tumors carry p53 gene mutations.

BiotechHealthtechLongevityCranbury, US

DHDavid H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Co-Founder & Member, Scientific Advisory Board)David H. Mack(Co-Founder, President & CEO)Thomas Shenk(Co-Founder)Deepika Jalota(Chief Development Officer)

Co-investorsAVAvoro Capital AdvisorsNENextech InvestRARA CapitalVIViking GlobalWEWellington ManagementOROrbiMed

Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.

AI & Machine LearningBiotechDigital HealthBoston, US

RVRehan Verjee(Co-Founder, Chief Executive Officer, Board Director)inSBSylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)inTCToni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)

Co-investors5A5AM VenturesILIllumina VenturesALAlexandriaLILilly Asia VenturesS2S28 Capital

Quantum Circuits develops superconducting quantum computers using dual-rail qubits with built-in error detection, designed to accelerate the path to fault-tolerant quantum computing.

Advanced ManufacturingDeep TechHardwareQuantum ComputingMadison, US

RSRob Schoelkopf(Sterling Professor, Founder)inLFLuigi Frunzio(Founder)RSRay SmetsinMichel Devoret(Founder)Robert Schoelkopf(Founder)

Co-investorsARARCH Venture PartnersCACanaan PartnersCOConnecticut InnovationsF-F-Prime CapitalFIFitz Gate VenturesINIn-Q-Tel+2 more

Quintessent develops optical connectivity solutions to address chip-to-chip communication bottlenecks in large-scale computing and AI systems.

AI & Machine LearningCloud ComputingDeep TechHardwareSemiconductorsSanta Barbara, US

ALAlan Liu(CEO, Co-Founder & Board Member)inBrian Koch(VP of Engineering & Co-Founder)inJBJohn Bowers(Chairman of the Board & Co-Founder)

Co-investorsENEntrada VenturesFOFoothill VenturesM M VenturesSISierra Ventures

San Diego biopharmaceutical company developing GPCR-targeted immune-inflammatory drugs; acquired by Celgene for ~$7.2B in 2015.

BiotechSan Diego, US

MBMarcus Boehm(Executive Officer)inRobert Peach(Executive Officer)inRSRaymond Stevens(Director)inFaheem Hasnain(Executive Officer, Director)inJSJames Schmidt(Executive Officer)inCMChrysa Mineo(Executive Officer)in

Co-investorsARARCH Venture PartnersRIRidgeback CapitalVEVenrockLILilly Ventures

ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs.

AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US

Dr. Daniel J. SiegwartArthur E Johnson(Executive Officer, Director)

Co-investorsAJAju IB InvestmentECEcoR1 CapitalEVEvolution VC PartnersMPMPM BioImpactOROrbiMedPFPfizer Venture Investments+6 more

Redona Therapeutics is a drug discovery company co-founded by Harvard Medical School investigators focused on novel areas of biology.

AI & Machine LearningBiotechBoston, US

George Daley(Co-founder)Richard Gregory(Co-founder)Frank Slack(Co-founder)Piotr Sliz(Co-founder)inKSKazumi Shiosaki(President & CEO)in

Co-investorsASAstellas Venture Management LLCSOSofinnova Partners

BiotechLexington, US

VMVictoria M. Richon(Executive Officer, Director)in

BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)

Co-investorsAVAvego BioScience CapitalPEPeregrine VenturesABAbbVieDEDeerfield Management CompanyJJJJDCNONovartis Venture Fund+3 more

Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.

BiotechHealthtechMedical DevicesSeattle, US

RMRichard Mulligan(Director)inHBHans Bishop(Founder)SHSteve Harr(Founder)JJJames J. MacDonald(Executive Officer)NHNathan Hardy(Executive Officer)

BoardGVGeoffrey von Maltzahn(Director)in

Co-investorsAMAmerican Family VenturesARARCH Venture PartnersCACatalytic Impact FoundationF-F-Prime CapitalFLFlagship PioneeringGVGV (Google Ventures)+8 more

Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101).

BiotechHealthtechMedical DevicesSouth San Francisco, US

JKJohn Kollins(Executive Officer, Director)Tadayoshi Iwashima(Executive Officer)TBThomas B. King(President and Board Director)inRJRob Janosky(Chief Commercial Officer)TOTom O'Neil(Chief Financial Officer)inDavid Prichard(Chief Operating Officer)

Co-investorsVIVivo CapitalWEWellington ManagementLULumira VenturesRARA CapitalRERed Tree VentureSBSBI Investment

Seismos provides an AI intelligence layer that converts acoustic signals and sensor measurements into real-time completion decisions for oil and gas well operators.

AI & Machine LearningDeep TechEnergyAustin, US

Panagiotis Adamopoulos(Executive Officer, Director)PAPanos Adamopoulos(Founder)inJeffrey Harris(Director)John Bain(Director)

BoardNDNoah Doyle(Director)in

Co-investorsEDEdison PartnersJAJavelin Venture Partners

SiFive develops processor IP based on the open-standard RISC-V instruction set architecture, offering customizable and scalable chip designs.

Deep TechHardwareSemiconductorsSan Francisco, US

YLYunsup Lee(Co-Founder & Chief Technology Officer)inKAKrste Asanovic(Co-Founder & Chief Architect)inAWAndrew Waterman(Co-Founder & Chief Engineer)inSAStefan A Dyckerhoff(Executive Officer, Director)inNSNaveed Sherwani(Executive Officer)inPLPatrick Little(Chairman, President & CEO)in

Co-investorsBEBerkeley SkyDeck FundCOCoatue ManagementIBIbex InvestorsINIntel CapitalPRProsperity7 VenturesQUQualcomm Ventures+9 more

The site is a Dutch-language affiliate portal that ranks and reviews online casinos targeting players in the Netherlands, offering casino comparisons, bonus guides, and gambling information.

ConsumerMedia & Entertainment

Co-investorsJAJavelin Venture PartnersUSUS Venture Partners

Snowcap Compute develops superconducting computing platforms using Josephson Junctions to replace semiconductor transistors, delivering orders-of-magnitude greater energy efficiency for AI and high-performance computing workloads.

AI & Machine LearningDeep TechSemiconductorsSan Francisco, US

AHAnna Herr(Founder)inQHQuentin Herr(Founder)inMichael Shamus Lafferty(Executive Officer, Director)Michael Lafferty(Founder)

BoardPGPat Gelsinger(Director)inRichard Hyman(Director)

Co-investorsPLPlayground GlobalATATEL VenturesCACambium CapitalPAPage One Ventures

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.

BiotechHealthtechMedical DevicesSouth San Francisco, US

JBJeffrey Bluestone(Founder)inJBJeff Bluestone, PhD(Founder and Scientific Advisor; co-founder and former President and CEO)QTQizhi Tang, PhD(Founder and Scientific Advisor)FRFred Ramsdell, PhD(Founder and Scientific Advisor)ARAlexander Rudensky, PhD(Founder and Scientific Advisor)Stephen Dilly, MBBS, PhD(President and Chief Executive Officer)

Co-investors8V8VCARARCH Venture PartnersFRFrazier Life SciencesGVGV (Google Ventures)JDJDRF T1D FundLALAV+6 more

StreetLight provides big data analytics for transportation planning and infrastructure investment decisions.

Climate TechData & InfrastructureGovTechLogistics & Supply ChainMobility & TransportationSan Francisco, US

PFPaul Friedman(Founder, Chief Technology Officer)inLSLaura Schewel(Executive Officer, Director, Promoter)in

BoardBill Perry(Director)Scott Pinizzotto(Director)MSMarc Singer(Director)inDarlene Mann(Director)

Co-investorsACACTIVATE CAPITAL PARTNERSWEWestern Technology Investment

Tessera provides a multi-agent AI platform for enterprise system modernization, automating processes across ERP, CRM, HCM, and finance systems with governed execution.

AI & Machine LearningEnterprise SoftwareSaaS

KNKabir Nagrecha(Chief Executive Officer)inMing Chang(Chief Operating Officer)inASAnirudh Sriram(Chief Technology Officer)inPGPrakash Gupta(Chief Revenue Officer)in

Co-investorsANAndreessen HorowitzCLClear VenturesFOFoundation CapitalMYMyriad Venture Partners

Trellis Air develops technology aimed at drying air using less energy.

CleantechClimate TechEnergySomerville, US

Russ Wilcox(Executive Officer, Director)

BoardCraig Shapiro(Director)

Co-investorsWOWorkshop Venture PartnersFOFounder Collective

Trulite Health builds Truity, a health optimization platform that delivers clinical, social, and behavioral decision support and patient-facing nudges to providers and care teams at the point of care.

Digital HealthHealthtechSaaSTempe, US

ACAlan C. Roga(Executive Officer, Director)inJohn Barravecchia(Executive Officer)inSLShaung Liu(Executive Officer)in

BoardCaleb DesRosiers(Director)

Co-investorsOSOsage Venture PartnersSEService Provider CapitalINInflect Health

Arcadia (urjanet.com) offers a platform that unifies utility bill and interval data, tariff and energy rate calculations, and solar and storage analysis into energy data and analytics.

CleantechClimate TechData & InfrastructureEnergyAtlanta, US

SMSANJOY MALIK(Executive Officer, Director)in

BoardPKPETER KIGHT(Director)inSFSTEVE FREDRICK(Director)inSIG MOSLEY(Director)DAVID RATCLIFFE(Director)

Co-investorsCOCorrelation VenturesGRGrotech VenturesOAOak HC/FTCOCommerce VenturesGRGRA VentureIMImlay Investments

Vanqua Bio is a biotechnology company developing molecules intended to become medicines for neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, and related neurological conditions.

BiotechDeep TechHealthtechLongevityChicago, US

Rand Sutherland(Director)inJSJim Sullivan(CEO)inKHKevin Hunt(CSO)in

BoardJSJonathan Silverstein(Director)inBernard Davitian(Director)Uya Chuluunbaatar(Director)

Co-investorsAVAvoro Capital AdvisorsOROrbiMedPOPontifax Venture CapitalCACasdin CapitalOMOmega Funds

Verdox develops an electrochemical carbon capture system that uses electrical energy alone to capture and release CO₂ from both industrial point sources and ambient air.

CleantechClimate TechDeep Tech

Alan Hatton(Founder)Brian Baynes(Founder)Sahag Voskian(Founder)

Co-investorsAZAzolla VenturesBRBreakthrough Energy VenturesLOLowercarbon CapitalPRPrime Impact Fund

Verve Motion develops the SafeLift exosuit, a wearable device designed to reduce workplace injuries and increase productivity for physically demanding jobs.

Future of WorkHardwareLogistics & Supply ChainRoboticsCambridge, US

IGIgnacio Galiana(Founder)in

Co-investors51515 VenturesCOConstruct CapitalCYCybernetix VenturesFOFounder CollectivePIPillar VCSASafar Partners

Virtue AI offers an enterprise AI security platform that applies real-time guardrails, red-teaming, and compliance controls to AI models and agentic systems.

AI & Machine LearningCybersecurityEnterprise SoftwareSan Francisco, US

SKSanmi Koyejo(Founder)inBLBo Li(Founder)inDSDawn Song(Founder)inCarlos Guestrin(Founder)in

Co-investorsLILightspeed Venture PartnersWAWalden Catalyst

Company producing world's first multi-material 3D printer capable of printing functional features with variable material properties.

Somerville, US

JAJennifer A. Lewis(Executive Officer, Director)

BoardJMJiong Ma(Director)CBClinton Bybee(Director)in

Co-investorsBRBraemar Energy VenturesINIn-Q-TelARARCH Venture Partners

Xscape Photonics develops laser light sources for AI infrastructure, including comb-based laser modules and wafer-scale integrated multicolor laser chiplets.

AI & Machine LearningDeep TechHardwareSemiconductorsFort Lee, US

AGAlexander Gaeta(Executive Officer, Director)inVRVivek Raghunathan(Co-Founder & CEO)inYoshitomo Okawachi(Executive Officer)Alexander Kash(Executive Officer, Director)Alex(Co-Founder & President)Yoshi(Co-Founder & VP of R&D)

Co-investorsCICisco InvestmentsFAFathom FundIAIAG Capital PartnersLILifeX VenturesNVNVIDIAADAddition+2 more